Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
57.60
-4.05 (-6.57%)
Feb 21, 2025, 4:00 PM EST - Market closed

Nutex Health Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Feb '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
3131211,237---
Market Cap Growth
-17.99%-90.24%----
Enterprise Value
5704371,484---
Last Close Price
57.6027.00285.00---
PS Ratio
0.960.495.64---
PB Ratio
4.971.5310.28---
P/TBV Ratio
3.585.0621.46---
P/FCF Ratio
15.47-34.39---
P/OCF Ratio
14.6996.1024.45---
EV/Sales Ratio
1.951.766.77---
EV/EBITDA Ratio
15.7369.891035.91---
EV/FCF Ratio
28.14-41.25---
Debt / Equity Ratio
3.803.492.220.931.022.36
Debt / EBITDA Ratio
8.0630.9760.690.980.953.15
Debt / FCF Ratio
14.98-7.431.315.89-
Asset Turnover
0.640.600.530.941.12-
Inventory Turnover
83.2856.4160.1063.7079.65-
Quick Ratio
1.681.451.694.004.250.61
Current Ratio
1.771.561.794.094.310.63
Return on Equity (ROE)
-35.10%-43.55%-277.48%99.44%146.88%-
Return on Assets (ROA)
3.76%-0.19%-0.69%30.90%39.25%-
Return on Capital (ROIC)
4.23%-0.22%-0.76%32.54%40.89%-
Return on Capital Employed (ROCE)
7.44%--48.69%55.28%32.41%
Earnings Yield
-13.13%-37.92%-34.34%---
FCF Yield
6.46%-6.82%2.91%---
Payout Ratio
0.00%--84.24%43.06%90.34%
Buyback Yield / Dilution
-10.96%-4.15%-7.10%---
Total Shareholder Return
-10.96%-4.15%-7.10%---
Source: S&P Capital IQ. Standard template. Financial Sources.